Rosebud Biosciences
Rosebud Biosciences is an early-stage startup focused on developing therapies for rare genetic diseases in children. Their approach involves creating organoid models that replicate a child's specific genetic mutation to screen for potential cures. They utilize advanced techniques such as micropatterned organoids derived from Human Induced Pluripotent Stem Cells (hiPSCs), which offer advantages over traditional methods. The company aims to accelerate drug discovery for genetic diseases by scaling up the process using organoid models, robotics, and machine learning, with the goal of finding treatments for the 95% of genetic diseases that currently lack targeted therapies. Rosebud is seeking pharmaceutical partners for drug development in areas like heart, liver, neural, and kidney diseases.
Rosebud Biosciences
Rosebud Biosciences is an early-stage startup focused on developing therapies for rare genetic diseases in children. Their approach involves creating organoid models that replicate a child's specific genetic mutation to screen for potential cures. They utilize advanced techniques such as micropatterned organoids derived from Human Induced Pluripotent Stem Cells (hiPSCs), which offer advantages over traditional methods. The company aims to accelerate drug discovery for genetic diseases by scaling up the process using organoid models, robotics, and machine learning, with the goal of finding treatments for the 95% of genetic diseases that currently lack targeted therapies. Rosebud is seeking pharmaceutical partners for drug development in areas like heart, liver, neural, and kidney diseases.